Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R. Wilson, Fiona Miall, Mayur Narkhede et al.|UCL Discovery (University College London)|2022Cited by 76
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Matthew S. Davids, Christoph Kornauth et al.|Blood|2021Cited by 37
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohortZoé Van de Wyngaert, S. Alfandari, Céline Berthon et al.|International Journal of Antimicrobial Agents|2019Cited by 27
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACEVincent Camus, Fabrice Jardin, Mathieu Viennot et al.|Blood Advances|2024Cited by 1
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell LymphomaJuliette Pénichoux, Vincent Camus, Pierre Decazes et al.|Hematological Oncology|2025Cited by 1